Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1
Background. Soluble suppression of tumorigenicity 2 protein (sST2) and tissue inhibitor of matrix metalloproteinase (TIMP)-1 are involved in multiple pathogenic pathways, including cardiac remodeling, which is the main pathology of atrial fibrillation (AF). This study aims to investigate the previou...
Saved in:
| Main Authors: | Wei-Ping Sun, Xiao Du, Jun-Jun Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | International Journal of Clinical Practice |
| Online Access: | http://dx.doi.org/10.1155/2022/6926510 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
by: A. O. Rubanenko, et al.
Published: (2018-11-01) -
MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01) -
Matrix metalloproteinases and their inhibitors
by: O. S. Grigorkevich, et al.
Published: (2019-02-01) -
The role of matrix metalloproteinase-9 and the tissue inhibitor of metalloproteinase — 1 in endogenous uveitis in children
by: M. A. Khrabrova, et al.
Published: (2024-03-01) -
The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)